Study of symptom improvement effect of Esomeprazole and vonoprazan in reflux esophagitis patients
Not Applicable
- Conditions
- Reflux esophagitis
- Registration Number
- JPRN-UMIN000020170
- Lead Sponsor
- Ishihara Gastroenterology clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
The patient that a serious heart, liver, renal function disorder, a patient developing a malignant neoplasm, a gastrointestinal tract resection, stomach esophagus junction rebuilding art, a patient having the past of the straying neurolysis, the combination taboo medicine of esomeprazole and vonoprazan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement rates in reflux symptoms after 2 and 4 weeks of treatment
- Secondary Outcome Measures
Name Time Method Change in reflux symptom score after treatment